Fast Science: Vetting Rapid Research During the COVID-19 Pandemic

By Alison Irvine

Paying for CRISPR Cures: The Economics of Genetic Therapies

By Alison Irvine

A Tale of Two CRISPRcons: The Evolution of a Conference

By Kevin Doxzen

What Are We Securing?

By Kevin Doxzen

When What Counts as “Security” Matters

By Nicholas Evans

The Stories of CRISPRcon

By Kevin Doxzen

Keystone Genome Engineering Final Thoughts

By Jacob Corn

Keystone Genome Engineering 1st Day Thoughts

By Jacob Corn